YAP1 and hepatocellular carcinoma: In Mst1/2-deficient livers, the YAP target Mcp1 triggers accumulation of tumor-infiltrating macrophages that impair immune clearance of transformed hepatocytes and promote HCC development (Guo et al., 2017; Kim et al., 2018).